Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

This study has suspended participant recruitment.

(Temporarily closed to accrual)

Sponsor:

Collaborator:

Information provided by (Responsible Party):

Children's Oncology Group

ClinicalTrials.gov Identifier:

NCT01175356

First received: August 3, 2010

Last updated: June 11, 2013

Last verified: June 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has suspended participant recruitment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2015 (Final data collection date for primary outcome measure)